• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthMartin Shkreli

‘Pharma Bro’ Martin Shkreli has been released from federal prison early

By
Patricia Hurtado
Patricia Hurtado
and
Bloomberg
Bloomberg
By
Patricia Hurtado
Patricia Hurtado
and
Bloomberg
Bloomberg
May 18, 2022, 2:37 PM ET

Martin Shkreli, the “Pharma Bro” who gained notoriety for unapologetically raising drug prices, has been released from federal prison in Pennsylvania and transferred to a halfway house.

Shkreli was sentenced in 2018 to 7 years in prison after being convicted of securities fraud for lying to investors and for manipulating shares of Retrophin Inc., a biotech company he founded. He was released early from a low-security federal prison in Allenwood, Pennsylvania. 

“While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time,” his lawyer Ben Brafman said in a statement.

Photos of Shkreli, 39, popped up Wednesday on the Twitter account of Edmund Sullivan, who was pictured next to him wearing a “Free Shkreli” t-shirt. A Facebook account bearing Shkreli’s name also posted a photo of him Wednesday with a caption saying “Getting out of real prison is easier than getting out of Twitter prison.”

Picked up this guy hitchhiking. Says he’s famous. Pic.twitter.com/7XrQaII7lq

— Edmund Sullivan (@edmundsullivan) May 18, 2022

Shkreli sought early release two years ago, telling a federal judge he “has been conducting significant research into developing molecules to inhibit the coronavirus” and would continue doing so if set free. The judge rejected that bid.  

Shkreli was freed from prison about four months ahead of his Sept. 14 release date. The U.S. Bureau of Prisons gives inmates time off for good behavior and also likely credited Shkreli for the six months he served in a federal jail in Brooklyn after asking followers for a strand of hair from former Secretary of State Hillary Clinton.

Sign up for the Coins2Day Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Authors
By Patricia Hurtado
See full bioRight Arrow Button Icon
By Bloomberg
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.